Cargando…
p185(HER‐2/neu) and p21(CIP1/WAF1) Expression in Primary Tumors and Lymph Node Metastases in Non‐small Cell Lung Cancer
p185(HER‐2/neu), a tyrosine kinase receptor, is one of the target molecules for cancer therapy, and its expression may reduce the sensitivity of tumor cells to anti‐cancer drugs. p21(CIP1/WAF1) is a cyclindependent kinase inhibitor, and its expression may also be involved in chemoresistance. Non‐sma...
Autores principales: | Akita, Kenji, Inagaki, Hiroshi, Sato, Shigeki, Niimi, Takashi, Maeda, Hiroyoshi, Ninomiya, Shigemitsu, Achiwa, Hiroyuki, Kawaguchi, Haruhiko, Yamakawa, Yosuke, Fujii, Yoshitaka, Shimizu, Shigeki, Eimoto, Tadaaki, Ueda, Ryuzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927126/ https://www.ncbi.nlm.nih.gov/pubmed/12359054 http://dx.doi.org/10.1111/j.1349-7006.2002.tb02477.x |
Ejemplares similares
-
Cytoplasmic p21(WAF1/CIP1 )expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis
por: Winters, Zoë E, et al.
Publicado: (2003) -
Epigenetic Regulation of p21(cip1/waf1) in Human Cancer
por: Ocker, Matthias, et al.
Publicado: (2019) -
Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.
por: Ito, Y., et al.
Publicado: (1996) -
Regenerative Response in Ischemic Brain Restricted by p21(cip1/waf1)
por: Qiu, Jianhua, et al.
Publicado: (2004) -
p21(WAF1/CIP1) Expression is Differentially Regulated by Metformin and Rapamycin
por: Molnar, Zoltan, et al.
Publicado: (2014)